Alkermes (ALKS) EPS (Weighted Average and Diluted) (2011 - 2026)

Alkermes (ALKS) has 12 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.4 in Q1 2026.

• EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.4, down 407.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.9 (down 56.1% YoY), and the FY2025 annual result was $1.43, down 34.1% from the prior year.
• EPS (Weighted Average and Diluted) declined to -$0.4 in Q1 2026 per ALKS's latest filing, from $0.29 in the prior quarter.
• Over five years, EPS (Weighted Average and Diluted) peaked at $1.38 in Q2 2023 and troughed at -$0.4 in Q1 2026.
• A 5-year average of $0.31 and a median of $0.49 in 2025 frame the typical range for EPS (Weighted Average and Diluted).
• On a YoY basis, EPS (Weighted Average and Diluted) climbed as much as 2850.0% in 2022 and fell as far as 1900.0% in 2022.
• A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.59 in 2022, then grew by 15.25% to $0.68 in 2023, then gained by 23.53% to $0.84 in 2024, then sank by 65.48% to $0.29 in 2025, then slumped by 237.93% to -$0.4 in 2026.
• Business Quant data shows ALKS's EPS (Weighted Average and Diluted) at -$0.4 in Q1 2026, $0.29 in Q4 2025, and $0.49 in Q3 2025.